Neurorehabilitation Devices Market Research Report - Forecast till 2027

神経リハビリテーションデバイス市場:タイプ別の情報(神経ロボットデバイス、ウェアラブルデバイス、非侵襲的刺激装置、ブレインコンピューターインターフェース)、アプリケーション(脳卒中、パーキンソン病、多発性硬化症、脊髄損傷、脳性麻痺、統合失調症、その他)、エンドユーザー(リハビリセンター、病院と診療所、在宅ケア)と地域(南北アメリカ、ヨーロッパ、アジア太平洋地域、その他の地域)-2027年までの予測

ID: MRFR/MED/1642-CR | February 2021 | Region: Global | 115 Pages         

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION 15

2.2 SCOPE OF THE STUDY 15

2.3 RESEARCH OBJECTIVE 15

2.4 MARKET STRUCTURE 15

2.5 ASSUMPTIONS & LIMITATIONS 16

3 RESEARCH METHODOLOGY

3.1 DATA MINING 17

3.2 SECONDARY RESEARCH 18

3.3 PRIMARY RESEARCH 19

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 20

3.5 FORECASTING TECHNIQUES 20

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21

3.6.1 BOTTOM-UP APPROACH 22

3.6.2 TOP-DOWN APPROACH 23

3.7 DATA TRIANGULATION 23

3.8 VALIDATION 23

4 MARKET DYNAMICS

4.1 OVERVIEW 24

4.2 DRIVERS 25

4.2.1 RISING NEUROLOGICAL DISORDERS 25

4.2.2 EFFECTIVENESS OF GAMING SYSTEM IN NEUROREHABILITATION 25

4.2.3 SURGE IN GERIATRIC POPULATION 26

4.2.4 EMERGING FIELD OF ROBOTIC REHABILITATION 26

4.3 RESTRAINTS 27

4.3.1 STRINGENT REGULATORY POLICIES 27

4.3.2 REQUIREMENT OF SKILLED PROFESSIONAL 28

4.4 OPPORTUNITIES 29

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS 30

5.1.1 R&D AND DESIGNING 31

5.1.2 MANUFACTURING 31

5.1.3 DISTRIBUTION 31

5.1.4 MARKETING AND SALES 31

5.1.5 POST-SALES MONITORING 31

5.2 PORTER’S FIVE FORCES MODEL 32

5.2.1 THREAT OF NEW ENTRANTS 33

5.2.2 BARGAINING POWER OF SUPPLIERS 33

5.2.3 THREAT OF SUBSTITUTES 33

5.2.4 BARGAINING POWER OF BUYERS 33

5.2.5 INTENSITY OF RIVALRY 33

6 NEUROREHABILITATION DEVICE MARKET, BY TYPE

6.1 INTRODUCTION 34

6.2 NEURO-ROBOTIC DEVICES 35

6.3 WEARABLE DEVICES 35

6.4 BRAIN COMPUTER INTERFACE (BCIS) 36

6.5 NON-INVASIVE STIMULATORS 37

7 NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

7.1 INTRODUCTION 38

7.2 BRAIN STROKE 39

7.3 PARKINSON’S 39

7.4 MULTIPLE SCLEROSIS 40

7.5 SPINAL CORD INJURY 41

7.6 CEREBRAL PALSY 41

7.7 SCHIZOPHRENIA 42

8 NEUROREHABILITATION DEVICE MARKET, BY END USER

8.1 INTRODUCTION 43

8.2 REHABILITATION CENTERS 44

8.3 HOSPITALS & CLINICS 44

8.4 HOME CARE 45

9 GLOBAL NEUROREHABILITATION DEVICE MARKET, BY REGION

9.1 INTRODUCTION 46

9.2 AMERICAS 47

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.2.1 NORTH AMERICA 49

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.2.1.1 US 50

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.2.1.2 CANADA 51

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.2.1.3 LATIN AMERICA 52

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.3 EUROPE 54

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.3.1 GERMANY 56

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.3.2 FRANCE 57

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.3.3 UK 58

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.3.4 ITALY 59

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.3.5 SPAIN 60

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.3.6 REST OF EUROPE 61

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.4 ASIA-PACIFIC 62

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.4.1 CHINA 64

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.4.2 JAPAN 65

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.4.3 INDIA 66

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.4.4 SOUTH KOREA 67

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.4.5 AUSTRALIA 68

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.4.6 REST OF ASIA-PACIFIC 69

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

9.5 ROW 70

NEUROREHABILITATION DEVICE MARKET, BY TYPE

NEUROREHABILITATION DEVICE MARKET, BY APPLICATION

NEUROREHABILITATION DEVICE MARKET, BY END USER

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW 72

10.2 COMPANY RANKING ANALYSIS 72

10.3 COMPETITIVE BENCHMARKING 73

10.4 COMPETITOR DASHBOARD 74

10.5 MAJOR GROWTH STRATEGY IN THE GLOBAL NEUROREHABILITATION DEVICES MARKET 75

10.6 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL NEUROREHABILITATION DEVICES

MARKET 76

10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 76

10.7.1 PRODUCT APPROVALS 77

10.7.2 AGREEMENT 77

10.7.3 PRODUCT LAUNCH 78

10.7.4 MERGER & COLLABORATION 78

10.7.5 PARTNERSHIP 79

10.7.6 EXPANSION 79

11 COMPANY PROFILES

11.1 HOCOMA AG 80

11.1.1 COMPANY OVERVIEW 80

11.1.2 FINANCIAL OVERVIEW 80

11.1.3 PRODUCTS/SERVICES OFFERED 80

11.1.4 KEY DEVELOPMENTS 80

11.1.5 SWOT ANALYSIS 81

11.1.6 KEY STRATEGIES 81

11.2 EKSO BIONICS HOLDINGS, INC. 82

11.2.1 COMPANY OVERVIEW 82

11.2.2 FINANCIAL OVERVIEW 82

11.2.3 PRODUCTS/SERVICES OFFERED 83

11.2.4 KEY DEVELOPMENTS 83

11.2.5 SWOT ANALYSIS 84

11.2.6 KEY STRATEGIES 84

11.3 REWALK ROBOTICS LTD 85

11.3.1 COMPANY OVERVIEW 85

11.3.2 FINANCIAL OVERVIEW 85

11.3.3 PRODUCTS/SERVICES OFFERED 86

11.3.4 KEY DEVELOPMENTS 86

11.3.5 SWOT ANALYSIS 86

11.3.6 KEY STRATEGIES 87

11.4 EODYNE 88

11.4.1 COMPANY OVERVIEW 88

11.4.2 FINANCIAL OVERVIEW 88

11.4.3 PRODUCTS/SERVICES OFFERED 88

11.4.4 KEY DEVELOPMENTS 88

11.4.5 SWOT ANALYSIS 89

11.4.6 KEY STRATEGIES 89

11.5 NEURO REHAB VR 90

11.5.1 COMPANY OVERVIEW 90

11.5.2 FINANCIAL OVERVIEW 90

11.5.3 PRODUCTS/SERVICES OFFERED 90

11.5.4 KEY DEVELOPMENTS 90

11.5.5 SWOT ANALYSIS 91

11.5.6 KEY STRATEGIES 91

11.6 NEOFECT 92

11.6.1 COMPANY OVERVIEW 92

11.6.2 FINANCIAL OVERVIEW 92

11.6.3 PRODUCTS/SERVICES OFFERED 92

11.6.4 KEY DEVELOPMENTS 93

11.6.5 SWOT ANALYSIS 93

11.6.6 KEY STRATEGIES 94

11.7 BIONESS INC. 95

11.7.1 COMPANY OVERVIEW 95

11.7.2 FINANCIAL OVERVIEW 95

11.7.3 PRODUCTS/SERVICES OFFERED 95

11.7.4 KEY DEVELOPMENTS 95

11.7.5 SWOT ANALYSIS 96

11.7.6 KEY STRATEGIES 96

11.8 BIONIK LABORATORIES CORP. 97

11.8.1 COMPANY OVERVIEW 97

11.8.2 FINANCIAL OVERVIEW 97

11.8.3 PRODUCTS/SERVICES OFFERED 98

11.8.4 KEY DEVELOPMENTS 98

11.8.5 SWOT ANALYSIS 99

11.8.6 KEY STRATEGIES 99

11.9 REHA TECHNOLOGY AG 100

11.9.1 COMPANY OVERVIEW 100

11.9.2 FINANCIAL OVERVIEW 100

11.9.3 PRODUCTS/SERVICES OFFERED 100

11.9.4 KEY DEVELOPMENTS 100

11.9.5 SWOT ANALYSIS 101

11.9.6 KEY STRATEGIES 101

11.10 REX BIONICS LTD 102

11.10.1 COMPANY OVERVIEW 102

11.10.2 FINANCIAL OVERVIEW 102

11.10.3 PRODUCTS/SERVICES OFFERED 102

11.10.4 KEY DEVELOPMENTS 102

11.10.5 SWOT ANALYSIS 103

11.10.6 KEY STRATEGIES 103

12 APPENDIX

12.1 REFERENCES 104

12.2 RELATED REPORTS 104

13 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 16

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19

TABLE 3 GLOBAL NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 34

TABLE 4 GLOBAL NEUROREHABILITATION DEVICE MARKET, BY TYPE, FOR NEURO-ROBOTIC DEVICES 2020-2027 (USD MILLION) 35

TABLE 5 GLOBAL NEUROREHABILITATION DEVICE MARKET, BY TYPE, FOR WEARABLE DEVICES 2020-2027 (USD MILLION) 36

TABLE 6 GLOBAL NEUROREHABILITATION DEVICE MARKET, BY TYPE, FOR BRAIN COMPUTER INTERFACE (BCIS) 2020-2027

(USD MILLION) 36

TABLE 7 GLOBAL NEUROREHABILITATION DEVICE MARKET, BY TYPE, FOR NON-INVASIVE STIMULATORS 2020-2027 (USD MILLION) 37

TABLE 8 GLOBAL NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 38

TABLE 9 GLOBAL NEUROREHABILITATION DEVICE MARKET, FOR BRAIN STROKE, BY REGION 2020-2027 (USD MILLION) 39

TABLE 10 GLOBAL NEUROREHABILITATION DEVICE MARKET, FOR PARKINSON’S, BY REGION 2020-2027 (USD MILLION) 40

TABLE 11 GLOBAL NEUROREHABILITATION DEVICE MARKET, FOR MULTIPLE SCLEROSIS, BY REGION 2020-2027 (USD MILLION) 40

TABLE 12 GLOBAL NEUROREHABILITATION DEVICE MARKET, FOR SPINAL CORD INJURY, BY REGION 2020-2027 (USD MILLION) 41

TABLE 13 GLOBAL NEUROREHABILITATION DEVICE MARKET, FOR CEREBRAL PALSY, BY REGION 2020-2027 (USD MILLION) 41

TABLE 14 GLOBAL NEUROREHABILITATION DEVICE MARKET, FOR SCHIZOPHRENIA, BY REGION 2020-2027 (USD MILLION) 42

TABLE 15 GLOBAL NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 43

TABLE 16 GLOBAL NEUROREHABILITATION DEVICE MARKET, FOR REHABILITATION CENTERS, BY REGION 2020-2027 (USD MILLION) 44

TABLE 17 GLOBAL NEUROREHABILITATION DEVICE MARKET, FOR HOSPITALS & CLINICS, BY REGION2020-2027 (USD MILLION) 44

TABLE 18 GLOBAL NEUROREHABILITATION DEVICE MARKET, FOR HOME CARE, BY REGION2020-2027 (USD MILLION) 45

TABLE 19 GLOBAL NEUROREHABILITATION DEVICE MARKET, BY REGION 2020-2027 (USD MILLION) 46

TABLE 20 AMERICAS NEUROREHABILITATION DEVICE MARKET, BY REGION 2020-2027 (USD MILLION) 47

TABLE 21 AMERICAS NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 48

TABLE 22 AMERICAS NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 48

TABLE 23 AMERICAS NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 48

TABLE 24 NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY REGION 2020-2027 (USD MILLION) 49

TABLE 25 NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 49

TABLE 26 NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 50

TABLE 27 NORTH AMERICA NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 50

TABLE 28 US NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 50

TABLE 29 US NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 51

TABLE 30 US NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 51

TABLE 31 CANADA NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 51

TABLE 32 CANADA NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 52

TABLE 33 CANADA NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 52

TABLE 34 LATIN AMERICA NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 52

TABLE 35 LATIN AMERICA NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 53

TABLE 36 LATIN AMERICA NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 53

TABLE 37 EUROPE NEUROREHABILITATION DEVICE MARKET, BY REGION 2020-2027 (USD MILLION) 54

TABLE 38 EUROPE NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 55

TABLE 39 EUROPE NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 55

TABLE 40 EUROPE NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 55

TABLE 41 GERMANY NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 56

TABLE 42 GERMANY NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 56

TABLE 43 GERMANY NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 56

TABLE 44 FRANCE NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 57

TABLE 45 FRANCE NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 57

TABLE 46 FRANCE NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 57

TABLE 47 UK NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 58

TABLE 48 UK NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 58

TABLE 49 UK NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 58

TABLE 50 ITALY NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 59

TABLE 51 ITALY NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 59

TABLE 52 ITALY NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 59

TABLE 53 SPAIN NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 60

TABLE 54 SPAIN NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 60

TABLE 55 SPAIN NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 60

TABLE 56 REST OF EUROPE NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 61

TABLE 57 REST OF EUROPE NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 61

TABLE 58 REST OF EUROPE NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 61

TABLE 59 ASIA-PACIFIC NEUROREHABILITATION DEVICE MARKET, BY REGION 2020-2027 (USD MILLION) 62

TABLE 60 ASIA-PACIFIC NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 63

TABLE 61 ASIA-PACIFIC NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 63

TABLE 62 ASIA-PACIFIC NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 63

TABLE 63 CHINA NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 64

TABLE 64 CHINA NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 64

TABLE 65 CHINA NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 64

TABLE 66 JAPAN NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 65

TABLE 67 JAPAN NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 65

TABLE 68 JAPAN NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 65

TABLE 69 INDIA NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 66

TABLE 70 INDIA NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 66

TABLE 71 INDIA NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 66

TABLE 72 SOUTH KOREA NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 67

TABLE 73 SOUTH KOREA NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 67

TABLE 74 SOUTH KOREA NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 67

TABLE 75 AUSTRALIA NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 68

TABLE 76 AUSTRALIA NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 68

TABLE 77 AUSTRALIA NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 68

TABLE 78 REST OF ASIA-PACIFIC NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 69

TABLE 79 REST OF ASIA-PACIFIC NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 69

TABLE 80 REST OF ASIA-PACIFIC NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 69

TABLE 81 ROW NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020-2027 (USD MILLION) 70

TABLE 82 ROW NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020-2027 (USD MILLION) 70

TABLE 83 ROW NEUROREHABILITATION DEVICE MARKET, BY END USER 2020-2027 (USD MILLION) 71

TABLE 84 MAJOR PLAYERS IN THE GLOBAL NEUROREHABILITATION DEVICES MARKET 72

TABLE 85 COMPETITOR DASHBOARD: GLOBAL NEUROREHABILITATION DEVICES MARKET 74

TABLE 86 THE MOST ACTIVE PLAYER IN THE GLOBAL NEUROREHABILITATION DEVICES MARKET 76

TABLE 87 PRODUCT APPROVALS 77

TABLE 88 AGREEMENT 77

TABLE 89 PRODUCT LAUNCH 78

TABLE 90 MERGER & COLLABORATION 78

TABLE 91 PARTNERSHIP 79

TABLE 92 EXPANSION 79

TABLE 93 HOCOMA AG: PRODUCTS/SERVICES OFFERED 80

TABLE 94 HOCOMA AG: KEY DEVELOPMENTS 80

TABLE 95 EKSO BIONICS HOLDINGS, INC.: PRODUCTS/SERVICES OFFERED 83

TABLE 96 EKSO BIONICS HOLDINGS, INC.: KEY DEVELOPMENTS 83

TABLE 97 REWALK ROBOTICS LTD: PRODUCTS/SERVICES OFFERED 86

TABLE 98 REWALK ROBOTICS LTD: KEY DEVELOPMENTS 86

TABLE 99 EODYNE: PRODUCTS/SERVICES OFFERED 88

TABLE 100 NEURO REHAB VR: PRODUCTS/SERVICES OFFERED 90

TABLE 101 NEURO REHAB VR: KEY DEVELOPMENTS 90

TABLE 102 NEOFECT: PRODUCTS/SERVICES OFFERED 92

TABLE 103 NEOFECT: KEY DEVELOPMENTS 93

TABLE 104 BIONESS INC.: PRODUCTS/SERVICES OFFERED 95

TABLE 105 BIONESS INC.: KEY DEVELOPMENTS 95

TABLE 106 BIONIK LABORATORIES CORP.: PRODUCTS/SERVICES OFFERED 98

TABLE 107 BIONIK LABORATORIES CORP.: PIPELINE PRODUCTS/SERVICES 98

TABLE 108 BIONIK LABORATORIES CORP.: KEY DEVELOPMENTS 98

TABLE 109 REHA TECHNOLOGY AG: PRODUCTS/SERVICES OFFERED 100

TABLE 110 REX BIONICS LTD: PRODUCTS/SERVICES OFFERED 102

14 LIST OF FIGURESs

FIGURE 1 MARKET SYNOPSIS 14

FIGURE 2 GLOBAL NEUROREHABILITATION DEVICES MARKET: STRUCTURE 15

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 22

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL NEUROREHABILITATION DEVICES MARKET 24

FIGURE 5 DRIVER IMPACT ANALYSIS 27

FIGURE 6 RESTRAINT IMPACT ANALYSIS 28

FIGURE 7 VALUE CHAIN ANALYSIS OF THE GLOBAL NEUROREHABILITATION DEVICES MARKET 30

FIGURE 8 PORTER’S FIVE FORCES MODEL 32

FIGURE 9 GLOBAL NEUROREHABILITATION DEVICE MARKET, BY TYPE 2020 & 2027 (USD MILLION) 34

FIGURE 10 GLOBAL NEUROREHABILITATION DEVICE MARKET, BY APPLICATION 2020 & 2027 (USD MILLION) 38

FIGURE 11 GLOBAL NEUROREHABILITATION DEVICE MARKET, BY END USER 2020 & 2027 (USD MILLION) 43

FIGURE 12 GLOBAL NEUROREHABILITATION DEVICE MARKET SHARE, BY REGION 2020 (%) 46

FIGURE 13 AMERICAS NEUROREHABILITATION DEVICE MARKET SHARE, BY REGION 2020 (%) 47

FIGURE 14 NORTH AMERICA NEUROREHABILITATION DEVICE MARKET SHARE, BY COUNTRY 2020 (%) 49

FIGURE 15 EUROPE NEUROREHABILITATION DEVICE MARKET SHARE, BY REGION 2020 (%) 54

FIGURE 16 ASIA-PACIFIC NEUROREHABILITATION DEVICE MARKET SHARE, BY COUNTRY/REGION 2020 (%) 62

FIGURE 17 BENCHMARKING OF MAJOR COMPETITORS 73

FIGURE 18 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE NEUROREHABILITATION DEVICES MARKET 75

FIGURE 19 GLOBAL NEUROREHABILITATION DEVICES MARKET, KEY DEVELOPMENTS & GROWTH STRATEGIES (%) 76

FIGURE 20 HOCOMA AG: SWOT ANALYSIS 81

FIGURE 21 EKSO BIONICS HOLDINGS, INC. FINANCIAL OVERVIEW 82

FIGURE 22 EKSO BIONICS HOLDINGS, INC.: SWOT ANALYSIS 84

FIGURE 23 REWALK ROBOTICS LTD FINANCIAL OVERVIEW 85

FIGURE 24 REWALK ROBOTICS LTD: SWOT ANALYSIS 86

FIGURE 25 EODYNE: SWOT ANALYSIS 89

FIGURE 26 NEURO REHAB VR: SWOT ANALYSIS 91

FIGURE 27 NEOFECT: SWOT ANALYSIS 93

FIGURE 28 BIONESS INC.: SWOT ANALYSIS 96

FIGURE 29 BIONIK LABORATORIES CORP FINANCIAL OVERVIEW 97

FIGURE 30 BIONIK LABORATORIES CORP.: SWOT ANALYSIS 99

FIGURE 31 REHA TECHNOLOGY AG: SWOT ANALYSIS 101

FIGURE 32 REX BIONICS LTD: SWOT ANALYSIS 103

神経リハビリテーション機器市場

神経リハビリテーション機器市場は2025年までに7億9300万ドルの収益を生み出し、2021年から2027年までの予測年数で16.4%のCAGRを記録すると予測されています。

セグメンテーション

タイプ別 Neuro Robotic Devices Wearable Devices Non Invasive Stimulators Brain Computer Interfaces
アプリケーション別 Brain Stroke Parkinson's Disease Multiple Sclerosis Spinal Cord Injury Cerebral Palsy Schizophrenia
By End User Rehabilitation Centers Hospitals & Clinics Home Care

キープレーヤー

  • Abbott Laboratories
  • Ekso Bionics Holdings Inc
  • Helius Medical Technologies
  • Hocoma AG
  • Medtronic Inc

運転手

  • The rise in neurological diseases
  • Technical advancements
  • Increase in the need for neurorehabilitation wearables and robotics.
Speak to Analyst Request a Free Sample

ニューロリハビリテーション機器市場の概要


神経学的リハビリテーションは、神経系に病気、怪我、または障害を持つ人々の治療のために設計された医師のチームによって監督されるプログラムです。理学療法の分野では、神経リハビリテーション装置が関与しており、運動能力の学習を促進します。神経リハビリテーションデバイスは、神経ロボットシステム、非侵襲的脳刺激装置、ブレインコンピューターインターフェース、およびウェアラブルデバイスで構成されています。これらのデバイスの助けを借りて、強度と品質の面でリハビリテーション製品の進歩と強化が行われました。これにより、神経リハビリテーション機器が神経障害において最適かつ本質的な転帰を確実にすることが保証されました。


ニューロリハビリテーション機器市場は2025年までに7億9300万ドルの収益を生み出すと予想されており、予測では16.4%のCAGRを記録すると予測されています2021年から2025年までの年です。今後数年間で、パーキンソン病は、最も高いCAGRで成長するように設定されるアプリケーションカテゴリの観点からの疾患です。また、脳卒中は2020年の主要なカテゴリーの1つです。市場では、ニューロリハビリテーション機器市場の成長のために企業が投資する新しい技術も革新されています。


COVID-19分析:


COVID-19は急速にパンデミック緊急事態になり、影響を受けた各国の医療制度は悲惨なものになりました。COVID-19は、非常に短時間で多くの人々の医療の必要性を判断し、世界中の緊急事態を乗り越えます。神経リハビリテーション、または神経学的リハビリテーションは、何らかの脳損傷を受けた患者の回復プロセスの重要な部分です。この間、特定の慈善団体は、脳損傷に苦しむ患者にさらなる支援を提供するために懸命に働いています。


新型コロナウイルス感染症の影響を過小評価することはできません。神経リハビリテーション機器および施設のサービスプロバイダーは、仮想または電話でセッションを提供することにより、驚異的な努力を払ってきました。患者のさまざまな障害の性質上、この未知の変化に対処することは非常に困難でした。これによる潜在的な影響を過小評価することはできません。


マーケットダイナミクス


パンデミック、新興企業や神経科学者の文化の成長の後、ニューロリハビリテーションデバイス市場は、自分たちのために金銭的成長を達成する。このニューロリハビリテーション機器市場に投資した人々は、この文化と市場動向を後押ししています。現在、現実には、患者は各アプリケーションセグメントについてリモートで相談しています。したがって、それは神経リハビリテーション機器産業に展望を与え、市場を推進するためにさまざまな個人と協力する機会を与えました。今後数年間で、パーキンソン病と脳卒中は、最も高いCAGRで成長するように設定されるアプリケーションカテゴリの観点からの疾患です。2020年のうち脳卒中が最も優勢なのはどれですか。市場では、ニューロリハビリテーション機器市場の成長のために企業が投資する新しい技術も革新されています。また、神経科学は完全な回復に役立っており、デバイスの可用性を確保し、すべての段階で治療を提供するための企業の努力も高まっています。


増加する高齢者人口



  • 神経学の上昇カリフォルニア病

  • 技術的進歩

  • 神経リハビリテーションウェアラブルとロボット工学の必要性が高まっています。


リハビリテーションロボット機器におけるロボット工学デバイスの開発は、非常に多くの感覚運動機能、すなわち腕、手を支援することによってパーソナライズされています。脚と足首。


今日、ウェアラブルとロボット工学は非常に多くの緊急事態で使用されており、企業は神経リハビリテーションデバイス市場の開発に注力しています目的に対して効率的です。


拘束



  • 熟練した専門家の不足

  • 高額な治療費

  • 厳しい規制


チャレンジ



  • 不十分な疫学研究

  • 政府はリハビリサービスにあまり注意を払っていません。


セグメントの概要


神経リハビリテーション機器市場は、タイプ、アプリケーション、およびエンドユーザーに基づいて分割されています。


タイプ別



  • ニューロロボットデバイス

  • ウェアラブルデバイス

  • 非侵襲的刺激装置

  • ブレイン・コンピューター・インターフェース (BCI)


アプリケーション別



  • 脳卒中

  • パーキンソン病

  • 多発性硬化症



  • Report Scope:
    Report Attribute/Metric Details
      Market Size   USD 793 Million (2025)
      CAGR   16.4% (2020-2025)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   type, application, end-user
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Abbott Laboratories,Ekso Bionics Holdings Inc,Helius Medical Technologies,Hocoma AG,Medtronic Inc,Others
      Key Market Opportunities

  • Non-sufficient epidemiological studies
  • Government pays less attention to rehab services.\r\n
  •   Key Market Drivers

  • The rise in neurological diseases\r\n
  • Technical advancements\r\n
  • Increase in the need for neurorehabilitation wearables and robotics.\r\n


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Neurorehabilitation Devices Market is projected to grow at a 6.3% CAGR between 2016-2022.

    Neurorehabilitation Devices Market is predicted to touch USD 2.25 billion by 2022.

    North America is expected to dominate the Neurorehabilitation Devices Market.

    Different end users of Neurorehabilitation Devices Market include research institutes, cognitive care centers, and hospitals/clinics.

    Lack of awareness and high device cost may limit market growth.